We have investigated the role of cyclin-dependent kinases in cell death and found that the expression of cyclin-dependent kinase 5 (Cdk5) is associated with apoptotic cell death in both adult and embryonic tissues. By double labeling immunohistochemistry and confocal microscopy, we specifically asso
Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35
✍ Scribed by Niranjana D. Amin; Wayne Albers; Harish C. Pant
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 170 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cyclin‐dependent kinase 5 (cdk5), in contrast to other members of the cyclin‐dependent kinase family, is not activated by cyclins but instead is activated by complexing with neuron‐specific activator molecules (p35, p39, and p67). The most effective activator of cdk5 both in vitro and in vivo is p35. We have taken a kinetic approach to study the interaction between p35, its various truncated forms, and cdk5 to understand better the mechanism of its activation. The cdk5 complexes formed with the truncated forms p25 and p21 produced similar maximum active kinase, whereas the cdk5 complexed with full‐length p35 and a further truncated form spanning amino acid residues from 138 to 291, with approximate molecular weight of 16 kDa (p16), produced slightly less (80%) activation than p25. P16 was the smallest fragment of p35 that produced activation equal to or greater than that of full‐length p35. By examination of further truncations of p16, we found that a small number of residues, 11 and 4 at the N‐ and C‐termini, respectively, of p16, are essential for cdk5 activation. Further truncation, removing both essential N‐ and C‐terminal domains, produces a peptide with markedly higher affinity for cdk5 compared with the peptides that retain either of these domains. Using these inactive truncated peptides as inhibitors, we examined the kinetics of activation. From these studies we conclude that activation involves at least three cdk5‐interacting domains, one located at each end of p16 and at least one located in a central domain. The cdk5 activation process is slow: The second‐order rate constant for p16 is about 1.2 μM^−1^ hr^−1^. On the basis of kinetic data, we suggest that cdk5 exists in two conformations. The inactive kinase conformation predominates in the absence of the activator. Activation occurs in two stages: a rapid and reversible interaction of cdk5 with its activator, which involves only one or two binding domains, followed by a slow stabilization of the active conformation as interaction with all three domains is achieved. Published 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Cyclin‐dependent kinase 5 (Cdk5)‐p35 is downregulated in cultured neurons by __N__‐methyl‐d‐aspartate (NMDA) via the proteasomal degradation of p35. However, it is not known where in neurons this downregulation occurs or the physiologic meaning of the reaction. We show the enrichment of
The ubiquitously expressed cyclinzone, which may restrict cdk5 activation to the postmidependent kinase 5 (cdk5) is essential for brain develtotic neural cells in the developing brain. The expresopment. Bioactivation of cdk5 in the brain requires sion levels of p35 and p39 mRNAs in the marginal the